PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Net Preferred Shares Issued and Repurchased (2023)

Updated

PharmaCyte Biotech (PMCB) posted Net Preferred Shares Issued and Repurchased of $33.65 million for FY2024 (year ended Apr 30, 2024).

Analysis

PharmaCyte Biotech (PMCB) Net Preferred Shares Issued and Repurchased (2023) Analysis & Trends

  • Annual Net Preferred Shares Issued and Repurchased shows a four-year compound annual growth rate of 7516.3% (FY2020 to FY2024).
  • The FY2024 figure stands as the lowest annual Net Preferred Shares Issued and Repurchased since FY2020.
  • Business Quant data shows PMCB's Net Preferred Shares Issued and Repurchased at $1.00 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 PharmaCyte Biotech 4.29 Mn 4.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2023 -1.35 Mn
Jul 31, 2023 35.00 Mn
API Access

PharmaCyte Biotech Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=PMCB&period=max&api_key=YOUR_API_KEY